Last week saw a large number of broker notes hitting the wires once again. Three buy ratings that caught my eye are summarised below.

Here’s why brokers think investors ought to buy them next week:

BWP Trust (ASX: BWP)

According to a note out of Ord Minnett, its analysts have upgraded this real estate investment trust’s shares to a buy rating with an improved price target of $4.40. The broker believes that BWP, which is predominantly a landlord to Bunnings Warehouse, is undervalued. Especially given its long leases. I agree with Ord Minnett on BWP and believe it is a great option for investors. This is particularly the case for income investors due to its attractive yield.

CSL Limited (ASX: CSL)

Analysts at Citi have retained their buy rating and $334.00 price target on this biotherapeutics company’s shares. The broker appears pleased with its decision to exercise its right to acquire Vitaeris and sees potential in its clazakizumab product. Outside this, the broker believes that increasing demand for flu vaccines could offset some of the potential weakness in plasma collections in FY 2021. I agree with Citi and would be a buyer of CSL’s shares.

Qantas Airways Limited (ASX: QAN)

A note out of UBS reveals that its analysts have retained their buy rating and lifted their price target on this airline operator’s shares to $5.50. According to the note, the broker believes there is a lot of pent up demand for travel and expects the domestic travel market to rebound strongly when border restrictions are lifted. This has led to the broker upgrading its earnings forecasts and lifting its price target accordingly. As long as there isn’t a second wave, I think Qantas could prove to be a good investment.

More reading

• You could beat the market in the 2020s with these ASX healthcare shares
• How I would build a balanced portfolio worth $100,000 with 10 ASX shares
• Should you buy CSL shares before it’s too late?
• Is the Qantas share price a buy today?
• 3 quality ASX dividend shares to solve your income needs

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Top brokers name 3 ASX 200 shares to buy next week appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/2XXr5Jm

If you’ve saved up a bit of cash and want to invest, you might have your eye on some ASX 200 shares trading cheaply.

Here are a couple of my top picks that you can snap up for under $10 per share today.

2 ASX 200 shares to buy for under $10

Harvey Norman Holdings Ltd (ASX: HVN) has been a bit of a surprise packet in 2020.

The Aussie retailer recently announced booming sales during the early stages of coronavirus restrictions. Aussie workers forced to work from home have been stocking up on office supplies and electronics from the Aussie retailer.

This sales boost even saw the ASX 200 retail share announce a 6 cents per share special dividend last week.

That’s good news for shareholders and we could see that trend continue if work from home becomes the ‘new normal’. The Harvey Norman share price is trading at $3.54 per share right now and could be a bargain buy.

Harvey Norman isn’t the only ASX 200 share that could be a steal for under $10. I also like the look of Mirvac Group (ASX: MGR) shares right now.

The Mirvac share price is trading at $2.36 per share after falling 25.8% lower this year.

Mirvac is a diversified real estate company with interests in residential, commercial and industrial assets. The Aussie developer has been hammered by the recent bear market with investors still unsure where the real estate sector is headed.

However, as the great Warren Buffett says, “be greedy when others are fearful“.

There’s no doubt investors are fearful right now with the S&P/ASX 200 Index (ASX: XJO) rocketing despite the bleak economic environment amid the pandemic. If you’re bullish on real estate, Mirvac could be a good ASX 200 share to buy.

The group still has a market capitalisation of $9.4 billion and trades at a price to earnings (P/E) ratio of 9.3.

The big question mark for me is the end of government stimulus measures later this year. These include mortgage holidays and payments to Aussie businesses and workers. That could put some stress on the real estate sector.

However, no one knows the future. We could just as easily see an extension of stimulus measures towards the end of the year.

Foolish takeaway

These are just a couple of ASX 200 shares that could be of good value for under $10 per share.

More reading

• Why we may be in danger of another coronavirus ASX market crash
• These were the best performing shares on the ASX 200 last week
• Why the Nearmap share price and one other are on my buy list
• 3 ASX dividend kings to buy and hold forever
• Got $20,000? These are the ASX shares I’d buy during COVID-19

Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Cheap ASX 200 shares I’d buy for less than $10 appeared first on Motley Fool Australia.

from Motley Fool Australia https://ift.tt/30GEB6a